AsthmaNCT00350376
Impact of Asthma Treatments on Daily Activities
An observational study of Asthma and Allergies, run by Ovation Research Group at 1 site in United States.
Trial summary
The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at… Read more about this study
- Who is it for?
- Ages 18 to 55 years
- How many people
- 1,500 participants
- Where
- 1 siteUnited States
- Study dates
- Jun 2006to not given
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- All sexes
- Adult
Who may be able to join
- Have asthma and allergies
- Currently taking Xolair® or Advair®
- Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair® for at least 12 months
- Between 18 and 55 years of age
- A non-smoker for at least 6 months
- Have internet access
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
United States1 site, 1 recruiting
- Recruiting
Ovation Research Group
San Francisco, California, 94105
Susan D Mathias, MPH
About this study
Official title: Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR)
The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.
- Keywords
- asthma, allergies, Xolair, Advair
- Medical subject headings
- Asthma, Hypersensitivity
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jul 2006 (estimated)
- Study startJun 2006
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AsthmaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Defined population
- Time perspective
- Other
- Enrolment
- 1,500 participants
Sponsor and investigators
- Lead sponsor
- Ovation Research Group
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Genentech, Inc.
- Investigators
- Susan D Mathias, MPH, Principal investigator, Ovation Research Group
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00350376
- Sponsor's protocol ID
- 1467
- Status last verified
- Jul 2006
- First submitted
- 5 Jul 2006
- Last updated
- 10 Jul 2006
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Jul 2006. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR)
- ClinicalTrials.gov ID
- NCT00350376
- Acronym / sponsor ID
- 1467
- Keywords
- asthma, allergies, Xolair, Advair
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,500 participants
- Lead sponsor
- Ovation Research GroupIndustry (pharma, biotech, devices)
- Collaborators
- Genentech, Inc.
- Study start
- Jun 2006
- First posted
- 10 Jul 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.
Study design
- Observational model
- Defined population
- Time perspective
- Other
Who may qualify
- Ages
- 18 to 55 years
- Sex
- All
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Have asthma and allergies
- Currently taking Xolair® or Advair®
- Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair® for at least 12 months
- Between 18 and 55 years of age
- A non-smoker for at least 6 months
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jul 2006.
Related trials for Asthma
RecruitingPhase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
Asthma
RecruitingPhase 1
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Asthma, Mild Asthma
RecruitingPhase 3
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Asthma Control
Active, not recruitingPhase 2/3
Local Antibiotic Delivery for Community Acquired Pneumonia
Community Acquired Pneumonia (CAP)
RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Susan D Mathias, MPH principal investigator
Ovation Research Group
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Asthma and Allergies, run by Ovation Research Group at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 10 Jul 2006. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Nita Ngo, MPH (888.631.9167, asthmastudy@ovation.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2006.